ロード中...

Use and Spending on Biologic Disease-modifying Anti-rheumatic Drugs for Rheumatoid Arthritis among U.S. Medicare Beneficiaries

OBJECTIVES: Biologic therapies have assumed an important role in treating rheumatoid arthritis (RA). We sought to investigate use, spending, and patient cost-sharing for Medicare beneficiaries using biologic drugs for RA, comparing patients exposed to minimal cost-sharing because of a Part D low-inc...

詳細記述

保存先:
書誌詳細
出版年:Arthritis Care Res (Hoboken)
主要な著者: Yazdany, Jinoos, Tonner, Chris, Schmajuk, Gabriela
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4573380/
https://ncbi.nlm.nih.gov/pubmed/25776035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22580
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!